Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fulgent Diagnostics

Fulgent Diagnostics?uq=w9if130k
2011 FOUNDED
PUBLIC STATUS
91-100 EMPLOYEES
FLGT STOCK SYMBOL
$4.38 SHARE PRICE (As of Wednesday Closing)
Description

Provider of cancer drug research services. The company offers cancer drug research, personalized cancer treatments, genetic testing and genetic diagnostic services.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 4978 Santa Anita Avenue
  • Suite 205
  • Temple City, CA 91780
  • United States

+1 (626) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Fulgent Diagnostics’s full profile, request a free trial.

Fulgent Diagnostics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.01 - $6.04 $78.6M $4.36 -$0.32 11.4K 17.9M

Fulgent Diagnostics Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 43,458 51,581 183,646
Revenue 18,837 18,730 18,276 9,576
EBITDA (4,757) (1,754) 2,088 (4,437)
Net Income (5,676) (2,510) (5,347) (8,314)
Total Assets 55,548 57,184 58,040 5,832
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Fulgent Diagnostics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Fulgent Diagnostics‘s full profile, request access.

Request full access to PitchBook

Fulgent Diagnostics Executive Team (3)

Name Title Board
Seat
Contact
Info
Ming Hsieh Co-Founder, Chairman & Chief Executive Officer
Paul Kim Chief Financial Officer
Harry Gao Ph.D Chief Scientific Officer & Lab Director

Fulgent Diagnostics Board Members (1)

Name Representing Role Since Contact
Info
0000 00000 Fulgent Diagnostics Co-Founder, Chairman & Chief Executive Officer 000 0000